Safety, Tolerability and Effectiveness of DTG/3TC vs BIC/TAF/FTC in PWH Without Antiretroviral Experience
Safety, Tolerability and Effectiveness of DTG/3TC vs BIC/TAF/FTC in PWH Without Antiretroviral Experience
Recruiting · NCT07031063 · Registry updated 2025-06-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety, Tolerability and Effectiveness of DTG/3TC vs BIC/TAF/FTC in PWH Without Antiretroviral Experience | Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, Insulin Resistance, Nutritional and Metabolic Diseases, RNA Virus Infections, Urogenital Diseases, glucose metabolism disease, hyperinsulinism, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, metabolic disease, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Recruiting | Phase 4 | 2025-06-26 | NCT07031063 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Instituto Mexicano del Seguro Social | 30 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hospital de infectología, Centro Médico Nacional La Raza | Mexico City | Mexico | 1 |